We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

881:HKEXZhongsheng Group Holdings Ltd. Analysis

Data as of 2026-03-16 - not real-time

¥1,949.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Keihanshin Building is trading at ¥1,949, comfortably above its recent support of ¥1,881 but still under the 20‑day SMA of ¥2,012, indicating a price that has slipped from short‑term averages while the longer‑term SMA hierarchy (20‑day > 50‑day > 200‑day) remains bullish. The RSI sits near 46, suggesting neutral momentum, yet the MACD line is negative with a bearish histogram, pointing to short‑term downside pressure. Valuation metrics are attractive – a trailing P/E of 19.3 is well below the industry average of 32.8 and the P/B of 1.16 is close to parity – but the balance sheet is leveraged, with a debt‑to‑equity ratio above 100% and net debt far exceeding cash reserves. The company delivers a solid 2.05% dividend yield on a 41% payout, and with a low beta (~0.15) and a 33% 30‑day volatility, market risk is modest while the Fear‑Greed Index signals “Extreme Greed,” hinting at bullish sentiment. Overall, the stock appears undervalued on a relative basis, yet the high leverage and mixed technical signals warrant a cautious stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above the identified support level
  • Bearish MACD histogram indicating potential near‑term pullback
  • Stable volume and low beta limiting abrupt moves

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Undervalued relative P/E compared with peers
  • Sustainable dividend yield with moderate payout ratio
  • High leverage requiring monitoring of debt servicing

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Attractive valuation metrics (P/E, P/B) versus industry averages
  • Consistent dividend income supporting total return
  • Low systematic risk (beta) and favorable macro sentiment

Key Metrics & Analysis

Financial Health

Revenue Growth2.00%
Profit Margin22.79%
P/E Ratio19.3
ROE5.91%
ROA2.03%
Debt/Equity100.69
P/B Ratio1.2
Industry P/E32.8

Technical Analysis

TrendBullish
RSI45.8
Support¥1,881.00
Resistance¥2,173.00
MA 20¥2,012.05
MA 50¥1,983.70
MA 200¥1,741.70
MACDBearish
VolumeStable
Fear & Greed Index79.45

Valuation

Target Price¥1,740.00
Upside/Downside-10.72%
GradeUndervalued
TypeBlend
Dividend Yield2.05%

Risk Assessment

Beta0.16
Volatility33.36%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.